<sentence id="0">Discussion</sentence>
<sentence id="1">Animal models of sepsis and myocardial injury <scope type="spec" id="0"> <cue type="spec" id="0">suggest</cue> that a beta-1-->3-D-glucan like GP mediates its protective mechanisms , in part , via a rapid shift from NFkappaB- to PI3K-signaling [ 22,37 ]</scope> .</sentence>
<sentence id="2">Our study provides novel evidence that downstream of recognition and signaling pro-inflammatory transcription factor binding and cytokine expression of human leukocytes is switched to an anti-inflammatory phenotype by GP .</sentence>
<sentence id="3">We confirmed and extended previous results [ 13-16 ] <scope type="spec" id="2"> <cue type="spec" id="2">indicating that</cue> , in the <scope type="neg" id="1"><cue type="neg" id="1">absence</cue> of other stimuli</scope> , beta-1-->3-D-glucans induced binding of NFkappaB- , NFIL-6- and NFAT-mers to cytokine promoters</scope> .</sentence>
<sentence id="4">Because of the multiple band shifts observed for NFAT binding ( Fig .</sentence>
<sentence id="5">1A ) , one could <scope type="spec" id="3"> <cue type="spec" id="3">speculate</cue> that there is activation of several different NFAT isoforms , <scope type="spec" id="4"> <cue type="spec" id="4">probably</cue> derived from alternative splicing [ 38</scope></scope> ] .</sentence>
<sentence id="6">Interestingly , the GP-induced transcription factor binding transformed only into a very limited cytokine response , namely IL-8 and IL-1RA ( Fig .</sentence>
<sentence id="7">3B ) .</sentence>
<sentence id="8">Hence , our data are in aggreement with the few reports describing a beta-1-->3-D-glucan-mediated IL-8 [ 6,16,19 ] and IL-1RA production [ 17 ] .</sentence>
<sentence id="9">In addition , our EMSA/supershift and immunoblotting results demonstrated a GP-mediated predominant binding of NFkappaB p65 and to a lesser extent of p50 to a kappaB consensus site of the IL-8 promoter ( Figs .</sentence>
<sentence id="10">1A , 2 ) .</sentence>
<sentence id="11">Results by Schulte and colleagues [ 28 ] pointed to an induction of IL-8 transcription depending on activation via an NFkappaB p65/65 homodimer , <scope type="neg" id="5"><cue type="neg" id="5">rather than</cue> via p65/50 heterodimers , which <scope type="spec" id="6"> <cue type="spec" id="6">might</cue> be the case for the GP-mediated IL-8 transcription</scope></scope> .</sentence>
<sentence id="12">A GP-mediated IL-8 transcription based upon a cooperation between transactivated NFkappaB p65 and NFIL-6 [ 13,39 ] or NFATc2 dimer binding to the IL-8kappaB site [ 38 ] <scope type="spec" id="7"> <cue type="spec" id="7">seems</cue> also <scope type="spec" id="8"> <cue type="spec" id="8">possible</scope></cue></scope> .</sentence>
<sentence id="13">The IL-8kappaB consensus site exhibits a preferentially p65 binding half site and thus differs from the kappaB half site described for TNFalpha and IL-1beta [ 27,40 ] , supporting the idea of regulating NFkappaB binding through combinatorial associations of the subunits and the specific sequence of the decameric kappaB motif [ 41,42 ] .</sentence>
<sentence id="14">Unlike LPS or TSST-1 , we found that GP did <scope type="neg" id="9"><cue type="neg" id="9">not</cue> induce IL-1beta</scope> , but it strongly induced IL-1RA , <scope type="spec" id="10"> <cue type="spec" id="10">suggesting</cue> an immediate anti-inflammatory potential of GP</scope> .</sentence>
<sentence id="15">Analysing the IL-1RA promoter [ 34 ] , we discovered four new binding sites ( Fig .</sentence>
<sentence id="16">8 ) : an NFkappaB3 site ( between -100 and -130 ) , an NFkappaB consensus site ( -266 and -280 ) , another NFkappaB2/3 site ( -288 and -302 ) and a more distal NFATP2/3 site ( -471 and -490 ) .</sentence>
<sentence id="17">Our data <scope type="spec" id="11"> <cue type="spec" id="11">indicated that</cue> GP leads to production of IL-1RA primarily via induction of NFATP2/3 and NFIL-6 DNA binding , which <scope type="spec" id="12"> <cue type="spec" id="12">might</cue> be due to differences in the binding motif or the composition of the activated transcription factors ( NFAT ) between the IFNgamma , IL-6 and IL-1RA promoter</scope></scope> .</sentence>
<sentence id="18">The differential decrease of NFkappaB , NFAT and NFIL-6 binding to sites in the IL-1RA promoter as well as of IL-1RA mRNA and protein induced by selective inhibitors prior to GP treatment <scope type="spec" id="13"> <cue type="spec" id="13">might</cue> <scope type="spec" id="14"> <cue type="spec" id="14">suggest</cue> that these steps are linked to each other and necessary for induction of IL-1RA ( Fig</scope></scope> .</sentence>
<sentence id="19">7 ) .</sentence>
<sentence id="20">Regarding cellular sources , both , monocytes as well as neutrophils have been reported to produce IL-1RA [ 32 ] .</sentence>
<sentence id="21">Flow cytometric experiments <scope type="spec" id="16"> <cue type="spec" id="16">seemed</cue> to confirm that monocytes and neutrophils were able to produce IL-8 just</scope> as IL-1RA in response to GP <scope type="neg" id="15">( data <cue type="neg" id="15">not</cue> shown )</scope> .</sentence>
<sentence id="22">This GP-induced cytokine profile was substantially more restricted than that of LPS or TSST-1 , which is <scope type="spec" id="17"> <cue type="spec" id="17">likely</cue> due to differences in recognition and signaling between LPS , TSST-1 and GP</scope> .</sentence>
<sentence id="23">Recognition of LPS is mainly mediated through Toll-like receptor 4 and subsequent signaling via the NFkappaB pathway , leading to expression of pro-inflammatory mediators like TNFalpha [ 43 ] .</sentence>
<sentence id="24">A bacterial superantigen like TSST-1 acts through binding to MHC-II molecules and subsequently the T cell receptor , leading to release of mainly IFNgamma and TNFalpha , the latter via both , PI3K and p38 mitogen-activated kinase signaling [ 44,45 ] .</sentence>
<sentence id="25">Altogether , the induction of the neutrophil-attracting IL-8 and the anti-inflammatory IL-1RA by fungal carbohydrates ( GP ) <scope type="spec" id="18"> <cue type="spec" id="18">may</cue> well fit to a benign PAMP response , mounting defensive mechanisms against a <scope type="spec" id="19"> <cue type="spec" id="19">possible</cue> microbial attack</scope></scope> .</sentence>
<sentence id="26">Potentially even more relevant than the specific cytokine panel induced by GP , we found that , in the presence of other stimuli ( LPS or TSST-1 ) , GP ameliorated their pro-inflammatory immune reactions , similar to the effects in murine models of sepsis and inflammation [ 21-24 ] .</sentence>
<sentence id="27">Mainly , GP altered the TSST-1-induced IL-1beta/IL-1RA ratio from a pro- to an anti-inflammatory profile via down-regulation of IL-1beta and IL-6 , at the same time there was a synergistic up-regulation of IL-1RA .</sentence>
<sentence id="28">In part , <scope type="spec" id="21"> this change <cue type="spec" id="21">may</cue> be caused by GP-mediated modulations of the TSST-1 induced binding of NFkappaB , NFIL-6 and NFAT to known and up to now <scope type="spec" id="22"> <cue type="spec" id="22">unknown</cue> sites within the IL-8 and IL-1RA promoter <scope type="neg" id="20"><cue type="neg" id="20">instead of</cue> the TNFalpha</scope> , IL-1beta , IL-6 or IFNgamma promoter</scope></scope> .</sentence>
<sentence id="29">Accordingly , we found that the TSST-1-induced binding of NFkappaB to sites from the TNFalpha promoter negatively correlated with the GP-mediated enhancement of the TSST-1-induced IL-1RA production ( r = -0.88 ; p < 0.01 ; data <scope type="neg" id="23"><cue type="neg" id="23">not</cue> shown in detail )</scope> .</sentence>
<sentence id="30">Of the four examined NFkappaB sites from the IL-1RA promoter , mostly the TSST-1- and LPS-induced binding to the NFkappaB3 and the TSST-1-induced binding to the new NFkappaB consensus site <scope type="spec" id="24"> <cue type="spec" id="24">seemed</cue> to be increased by GP</scope> .</sentence>
<sentence id="31">So , while we observed a GP-mediated down-regulation of the LPS- and the TSST-1-induced NFkappaB binding to sites of the TNFalpha promoter , there was an up-regulation to NFkappaB3 and NFkappaB consensus sites of the IL-1RA promoter .</sentence>
<sentence id="32">These seemingly contradictory data could be explained by differences in either NFkappaB subunits or conserved nucleotides ( # 1 , 2 , 3 , 10 ) within the decameric NFkappaB binding motif between the TNFalpha and the IL-1RA promoter ( for NFkappaB3 the IL-1RA motif contains a T on position 10 <scope type="neg" id="25"><cue type="neg" id="25">instead of</cue> the conserved C in the TNFalpha motif , see Table 1 ) , <scope type="spec" id="26"> <cue type="spec" id="26">probably</cue> leading to differences in binding</scope> [ 41,42</scope> ] .</sentence>
<sentence id="33">Despite the location of the new NFkappaB consensus site ( -266 and -280 ) in the inhibitory element ( -250 and -294 ) of the IL-1RA promoter [ 30 ] , we observed <scope type="neg" id="27"><cue type="neg" id="27">no</cue> inhibition</scope> .</sentence>
<sentence id="34">On the other side , we found an inhibitory NFkappaB2/3 site ( -288 and -302 ) towards the end of the inhibitory element , demonstrating down-regulations of the LPS- and TSST-1-induced binding , <scope type="spec" id="29"> <scope type="neg" id="28">which <cue type="neg" id="28"><cue type="spec" id="29">could</cue> not</cue> be altered by GP</scope></scope> .</sentence>
<sentence id="35">In our opinion , this site <scope type="spec" id="30"> <cue type="spec" id="30">may</cue> therefore represent at least a part of the previoulsy described inhibitory element [ 30 ]</scope> .</sentence>
<sentence id="36">The GP-modulated increase in TSST-1-induced binding to the new NFkappaB3 and NFkappaB consensus site , the NFIL-6 site [ 32 ] as well as to the novel NFATP2/3 site <scope type="spec" id="31"> <cue type="spec" id="31">may</cue> explain the synergistic up-regulation of the TSST-1-induced IL-1RA production</scope> .</sentence>
<sentence id="37">We <scope type="spec" id="32"> <cue type="spec" id="32">think</cue> that this GP-modulated activation of transcription was reflected by the decrease of the IL-1beta/IL-1RA ratio following GP + TSST-1 ( Fig</scope> .</sentence>
<sentence id="38">6 ) .</sentence>
<sentence id="39">In this context , it has been postulated that in vitro a 100fold excess of IL-1RA over IL-1beta <scope type="spec" id="33"> <cue type="spec" id="33">might</cue> control the biological effects of IL-1 [ 46,47</scope> ] .</sentence>
<sentence id="40">Since , in fact , the IL-1beta/IL-1RA ratio following GP + TSST-1 is partially less than 0.01 , it is <scope type="neg" id="34"><cue type="neg" id="34">not</cue> unreasonable to assume that IL-1beta bioactivity is inactivated in our system</scope> .</sentence>
<sentence id="41">Indeed , GP reduced the TSST-1-induced , IL-1-dependent IL-2 production of murine EL-4 cells <scope type="neg" id="35">( data <cue type="neg" id="35">not</cue> shown in detail )</scope> .</sentence>
<sentence id="42"><scope type="spec" id="36"> The weaker modulating effects of GP on the LPS-induced immune response observed in this study , <cue type="spec" id="36">may</cue> be attributed to delicately balanced differences in signaling pathways between LPS and TSST-1 [ 43-45 ]</scope> .</sentence>
<sentence id="43">TSST-1 has been shown to use the PI3K pathway for signaling [ 44 ] and this effect <scope type="spec" id="37"> <cue type="spec" id="37">may</cue> be sustained by GP treatment [ 22,37 ]</scope> .</sentence>
<sentence id="44">It has been demonstrated that in septic/LPS-adapted leukocytes the PI3K pathway selectively controls sIL-1RA but <scope type="neg" id="38"><cue type="neg" id="38">not</cue> IL-1beta production [ 48 ]</scope> .</sentence>
<sentence id="45">Signaling via PI3K has been reported to be involved in the activation of NFAT in T cells [ 49 ] .</sentence>
<sentence id="46">Activation of NFkappaB can also take place via PI3K [ 50 ] , which <scope type="spec" id="39"> <cue type="spec" id="39">may</cue> offer an explanation for a difference in signaling between GP ( PI3K ) and LPS ( mitogen-activated kinase signaling )</scope> .</sentence>
<sentence id="47"><scope type="spec" id="41"> This idea <cue type="spec" id="41">may</cue> be supported by another study showing that despite the use of similar PRR , LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins and acted synergistically in combination , <scope type="spec" id="42"> <cue type="spec" id="42">suggestive</cue> of signals which are <scope type="neg" id="40"><cue type="neg" id="40">not</cue> equivalent in all parts [ 51</scope></scope> ]</scope> .</sentence>